Congress’ Passage Of Anabolic Steroid Bill Hailed By Supplements Industry

The Designer Anabolic Steroid Control Act (DASCA) of 2014 has been passed by the US Senate. The bill is now waiting for US President Barrack Obama for signature.

Passage of the DSAC was welcomed by the Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry. CRN said the bill will protect consumers from potentially dangerous anabolic steroids falsely marketed as dietary supplements.

CRN President & CEO Steve Mister said we are extremely grateful to Congress for passing this important piece of legislation and particularly want to acknowledge Sens. Sheldon Whitehouse (D-RI) and Orrin Hatch (R-UT), and Reps. Joe Pitts (R-PA) and Frank Pallone (D-NJ), sponsors of the bill respectively in the Senate and the House. The CRN President added we are thankful as well to other legislators and industry stakeholders who kept the serious issue of designer anabolic steroids in front of key colleagues in Congress.

Steve added passage of this bill was one of CRN’s top legislative priorities this year, as responsible member companies want to do all that they can to solve the problem of anabolic steroids illegally being sold as dietary supplements. Mister observed when criminal outliers are not stopped, not only does it put consumers at risk, but it unjustly blackens the reputation of responsible dietary supplement companies that manufacture and market legitimate, high-quality and beneficial supplements for sports nutrition and performance. He added the passage of DASCA brings a welcome protection against that.

The bill will make it easier for federal authorities to prohibit the production and ban dozens of active ingredients now used in the production of anabolic steroids and similar products.

In a statement, Sen. Orrin Hatch, one of the bill’s sponsors, said designer steroids are produced by reverse engineering existing illegal steroids and then slightly modifying their chemical composition, so the resulting product is not on the Drug Enforcement Administration’s (DEA) list of controlled substances.

The DSAC bans 25 designer steroid ingredients that are already known to federal regulators from being sold over the counter by adding them to the Controlled Substances Act (CSA) as Schedule III drugs. It also allows other drug ingredients that are in “chemical structure substantially similar to one or more anabolic steroids” added to the Controlled Substances Act by the DASCA to also be regulated as anabolic steroids.  The Designer Anabolic Steroid Control Act will allow the Drug Enforcement Administration to quickly crack down on criminals who create new anabolic substances that closely resemble red-flagged counterparts listed.

      This bill also creates a new “temporary” scheduling process by which the Drug Enforcement Administration can issue a temporary order adding a drug or other substance to the definition of anabolic steroids if it considers it to be an anabolic steroid. The bill states the Drug Enforcement Administration may also pursue permanent rulemaking to add the drug substances to the Controlled Substances Act. The Designer Anabolic Steroid Control Act of 2014 also increases penalties for importing, exporting, manufacturing, distributing, or dispensing anabolic steroids unless the products are clearly identified as an anabolic steroid or is approved by the US Food and Drug Administration (FDA).

pdf_iconDownload in PDF: Congress’ Passage Of Anabolic Steroid Bill Hailed By Supplements Industry